Literature DB >> 26546064

Management of congenital pseudarthrosis of the tibia with the Ilizarov method in a paediatric population: influence of aetiological factors.

Dmitry Y Borzunov1, Alexander Y Chevardin2, Alexander I Mitrofanov1.   

Abstract

PURPOSE: Our study compared the rates of union achieved with the Ilizarov method in congenital pseudarthrosis of the tibia (CPT) associated with neurofibromatosis type 1 (NF1) or CPT of idiopathic origin in paediatric patients.
METHODS: We studied the outcomes of 28 children that were treated for CPT between 2005 and 2013. Group 1 included children (n = 14, mean age = 9.7 years) with CPT associated with NF1 while group 2 were CPT cases that had radiographic confirmation of dysplastic lesions in the tibia but lacked clinical NF1 manifestations (n = 14, mean age = 8.6 years). There was no statistical difference between the groups regarding their age or number of previous operations per patient. Individual technical solutions were planned for each patient but coaptation of bone fragments and autologous local tissue grafting to achieve a greater bone thickness and contact area at the pseudarthrosis level were mainly used. Refracture-free rate after the first operation, number of re-operations per patient, and union rates in the groups were compared.
RESULTS: Bone union and weight bearing were obtained in all the cases after the first operation. Refracture-free rate was 42.86 % in group 1 and 35.71% in group 2 (no statistical difference, p > 0.05). Mean number of re-operations per patient was 1.07 and 0.78 respectively (p > 0.05). Subsequent treatment for refractures with the Ilizarov techniques gained 92.86% of union in both groups at the follow-ups by completion of the study (range, 2-9 years).
CONCLUSIONS: The Ilizarov method yields comparable results in the management of CPT associated with NF1 or tibial dysplasia of idiopathic origin in paediatric cases. Further research should focus on the ways to support the Ilizarov method in order to reduce the number of repetitive surgeries or eliminate them.

Entities:  

Keywords:  Congenital pseudarthrosis of the tibia; Ilizarov method; Neurofibromatosis type 1; Tibial dysplasia

Mesh:

Year:  2015        PMID: 26546064     DOI: 10.1007/s00264-015-3029-7

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  28 in total

1.  A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues.

Authors:  A Sakamoto; Y Oda; Y Iwamoto; M Tsuneyoshi
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

2.  Treatment of congenital pseudarthrosis of the tibia: a multicenter study in Japan.

Authors:  Isao Ohnishi; Wakyo Sato; Juntarou Matsuyama; Hiroshi Yajima; Nobuhiko Haga; Makoto Kamegaya; Akio Minami; Masato Sato; Shinji Yoshino; Takashi Oki; Kozo Nakamura
Journal:  J Pediatr Orthop       Date:  2005 Mar-Apr       Impact factor: 2.324

3.  Congenital pseudoarthrosis of the tibia: healing by lengthening over a rod without compression of the nonunion. A preliminary report.

Authors:  Muhammad Kamal Muhammad Abdul Jamil; Abdul Halim Abdul Rashid; Sharaf Ibrahim
Journal:  J Pediatr Orthop B       Date:  2013-05       Impact factor: 1.041

4.  A regenerative approach for bone repair in congenital pseudarthrosis of the tibia associated or not associated with type 1 neurofibromatosis: correlation between laboratory findings and clinical outcome.

Authors:  Donatella Granchi; Valentina Devescovi; Serena Rubina Baglio; Marina Magnani; Onofrio Donzelli; Nicola Baldini
Journal:  Cytotherapy       Date:  2011-11-22       Impact factor: 5.414

Review 5.  Neurofibromatosis in children: the role of the orthopaedist.

Authors:  A H Crawford; E K Schorry
Journal:  J Am Acad Orthop Surg       Date:  1999 Jul-Aug       Impact factor: 3.020

Review 6.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.

Authors:  Rosalie E Ferner; Susan M Huson; Nick Thomas; Celia Moss; Harry Willshaw; D Gareth Evans; Meena Upadhyaya; Richard Towers; Michael Gleeson; Christine Steiger; Amanda Kirby
Journal:  J Med Genet       Date:  2006-11-14       Impact factor: 6.318

7.  Epidemiology and treatment outcome of congenital pseudarthrosis of the tibia.

Authors:  Joachim Horn; Harald Steen; Terje Terjesen
Journal:  J Child Orthop       Date:  2013-01-18       Impact factor: 1.548

8.  [Fibrous dysplasia and osteofibrous dysplasia].

Authors:  G U Exner; A R von Hochstetter
Journal:  Orthopade       Date:  1995-02       Impact factor: 1.087

Review 9.  Congenital pseudarthrosis of the tibia.

Authors:  Kelly L Vander Have; Robert N Hensinger; Michelle Caird; Charles Johnston; Frances A Farley
Journal:  J Am Acad Orthop Surg       Date:  2008-04       Impact factor: 3.020

10.  Association of Ilizarov's technique and intramedullary rodding in the treatment of congenital pseudarthrosis of the tibia.

Authors:  Laurent Mathieu; Raphaël Vialle; Camille Thevenin-Lemoine; Pierre Mary; Jean-Paul Damsin
Journal:  J Child Orthop       Date:  2008-10-28       Impact factor: 1.548

View more
  13 in total

1.  Functional and radiological outcomes after treatment of congenital pseudarthrosis of the tibia using the Ilizarov technique: a retrospective single-center study.

Authors:  Ahmed Ibrahim Zayda; Mohamed Kamal Mesregah; Soliman Hassan Zalalo; Samy Abdel-Hady Sakr
Journal:  J Orthop Traumatol       Date:  2022-09-23

2.  Combination of the Ilizarov Method and Intramedullary Fixation for the Treatment of Congenital Pseudarthrosis of the Tibia in Children: A Retrospective Observational Study.

Authors:  Ainizier Yalikun; Maimaiaili Yushan; Yimurang Hamiti; Cheng Lu; Aihemaitijiang Yusufu
Journal:  Front Surg       Date:  2022-05-17

3.  Analysis of risk factors affecting union and refracture after combined surgery for congenital pseudarthrosis of the tibia: a retrospective study of 255 cases.

Authors:  Zhuoyang Li; Hui Yu; Yiyong Huang; Yaoxi Liu; Guanghui Zhu; Qian Tan; Haibo Mei; Ge Yang
Journal:  Orphanet J Rare Dis       Date:  2022-06-23       Impact factor: 4.303

4.  Are Children Suffering From Congenital Pseudarthrosis of the Tibia Associated With Decreased Bone Strength?

Authors:  Ge Yang; Siyu Xu; Haibo Mei; Guanghui Zhu; Yaoxi Liu; Qian Tan; Hui Yu
Journal:  Front Pediatr       Date:  2022-05-09       Impact factor: 3.569

5.  Combined technique with hydroxyapatite coated intramedullary nails in treatment of anterolateral bowing of congenital pseudarthrosis of tibia.

Authors:  Dmitry Popkov; Arnold Popkov; Siniša Dučić; Mikan Lazović; Pierre Lascombes
Journal:  J Orthop       Date:  2019-11-12

Review 6.  Contribution of G.A. Ilizarov to bone reconstruction: historical achievements and state of the art.

Authors:  Alexander V Gubin; Dmitry Y Borzunov; Larisa O Marchenkova; Tatiana A Malkova; Irina L Smirnova
Journal:  Strategies Trauma Limb Reconstr       Date:  2016-07-18

7.  Stem cell therapy for enhancement of bone consolidation in distraction osteogenesis: A contemporary review of experimental studies.

Authors:  Y Yang; S Lin; B Wang; W Gu; G Li
Journal:  Bone Joint Res       Date:  2017-06       Impact factor: 5.853

8.  Congenital pseudarthrosis of the tibia: biological and biomechanical considerations to achieve union and prevent refracture.

Authors:  D Paley
Journal:  J Child Orthop       Date:  2019-04-01       Impact factor: 1.548

9.  Combined surgery with 3-in-1 osteosynthesis in congenital pseudarthrosis of the tibia with intact fibula.

Authors:  Yaoxi Liu; Ge Yang; Kun Liu; Jiangyan Wu; Guanghui Zhu; Jin Tang; Yu Zheng; Haibo Mei
Journal:  Orphanet J Rare Dis       Date:  2020-03-02       Impact factor: 4.123

10.  Anterolateral Bowing of Congenital Pseudoarthrosis of Tibia Treated by Percutaneous Osteotomy and Gradual Correction Using Taylor Spatial Frame, then Late Insertion of a Fussier-Duval Nail: A Case Report.

Authors:  Rami Jahmani; Mohammed Alorjani
Journal:  Am J Case Rep       Date:  2018-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.